| 中国医药 （600056） 重要财务指标 |
| 2008-6-30 | 2008-3-31 | 2007-12-31 | | 每股收益摊薄 | 0.333 | 0.125 | 0.982 | | 每股收益加权平均 | 0.333 | 0.125 | 0.980 | 每股收益摊薄
（扣除非经常性损益后） | | | | 每股收益加权平均
（扣除非经常性损益后） | 0.231 | 0.110 | 0.360 | | 每股净资产 | 4.820 | 5.514 | 5.990 | | 每股净资产（调整后） | | | | | 每股经营活动产生的现金流量净额 | -0.101 | -0.048 | -0.120 | | 净资产收益率摊薄（%） | 6.90 | 2.26 | 16.38 | | 净资产收益率加权（%） | 6.58 | | 17.85 | | 主营业务收入 | 1,451,481,969.13 | 671,088,002.22 | 2,475,160,441.66 | | 主营业务利润 | 172,889,790.06 | 81,004,280.92 | 300,010,338.53 | | 营业利润 | 125,942,919.94 | 47,890,148.81 | 317,919,139.81 | | 投资收益 | 37,533,685.03 | 4,483,367.28 | 204,755,519.83 | | 营业外收支净额 | | | | | 利润总额 | 123,630,258.83 | 47,799,813.42 | 322,189,378.52 | | 净利润 | 79,553,279.71 | 29,805,583.79 | 234,853,364.05 | | 净利润（扣除非经常性损益后） | 55,358,734.56 | | 85,391,919.56 | | 经营活动产生的现金流量净额 | -24,209,190.80 | -11,478,381.41 | -27,557,028.42 | | 现金及现金等价物净增加额 | -84,989,173.49 | -61,479,647.13 | 26,961,778.65 | | 流动资产 | 1,832,123,335.14 | 1,740,067,140.49 | 1,654,941,754.42 | | 流动负债 | 1,195,754,322.30 | 1,075,522,114.83 | 985,699,237.97 | | 总资产 | 2,604,243,187.95 | 2,680,278,531.72 | 2,722,894,540.36 | | 股东权益不含少数股东权益 | 1,152,984,888.06 | 1,318,847,182.58 | 1,433,363,184.88 |
|
